Article Details

HHS awards $590 million to Moderna to develop mRNA vaccines against pandemic flu threats

Retrieved on: 2025-01-21 21:34:40

Tags for this article:

Click the tags to see associated articles and topics

HHS awards $590 million to Moderna to develop mRNA vaccines against pandemic flu threats. View article details on hiswai:

Excerpt

HHS said Moderna will develop and assess an mRNA vaccine against H7N9 avian influenza in a phase 3 clinical trial. The company will also design up to ...

Article found on: www.cidrap.umn.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up